Skip to main content

Regencell Bioscience Holdings Ltd

corporate_fare Company Profile

Regencell Bioscience Holdings Ltd

RGC·NASDAQ·Life Sciences·CIK 0001829667

Regencell Bioscience Holdings Limited is a holding company incorporated in the Cayman Islands on October 30, 2014. It holds all the issued and outstanding shares of its wholly-owned subsidiaries: Regencell Bioscience Limited, Regencell Limited, and Regencell Bioscience North America Limited. The company conducts its business through these subsidiaries. Regencell Bioscience Limited was incorporated in Hong Kong on May 12, 2015. Regencell Limited was incorporated in Hong Kong on November 20, 2014. Regencell Bioscience North America Limited was incorporated in the British Virgin Islands on April 25, 2022. The company's principal executive offices are located at 9/F Chinachem Leighton Plaza, 29 Leighton Road, Causeway Bay, Hong Kong.

Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is a publicly traded company in the Life Sciences sector. Wiseek monitors RGC SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Regencell Bioscience Hit With Class Action Lawsuit Alleging Market Manipulation, DOJ Probe
  • Regencell Bioscience Finalizes $20M Direct Offering at 27% Discount
  • Regencell Bioscience Finalizes $20M Direct Offering at 25% Discount with Institutional Investor
  • Regencell Bioscience Secures $20M in Deeply Discounted Offering
  • Regencell Bioscience Reports Deepening Losses, Going Concern Doubt, and Ongoing DOJ Investigation

Financial Snapshot

Fiscal year ended June 30, 2025
Net Income
-$3.58M
Diluted EPS
-$0.72
Op. Cash Flow
-$3.11M
Free Cash Flow
-$3.27M
Operating Income
-$3.77M
Cash & Equivalents
$2.42M
Debt / Equity
0.00×
Shares Outstanding
494.49M sh
Source: 20-F · filed 2025-10-31 · accession 0001213900-25-104686

Insider Transactions

RGC files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with R →
$18.83
52-week range · as of 2026-05-19 $7.89 – $83.6
Market cap
$9.33B
Volume
85.2K (0.9× avg)
3-mo avg 99.6K
Live data · 2026-06-14 03:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RGC - Latest Insights

RGC
May 21, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $27.60
Real-time Price: $18.83 info
Change: -$8.77 (-32%) info
Market Cap: $9.33B info
RGC
May 19, 2026, 5:10 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $27.00
Real-time Price: $18.83 info
Change: -$8.17 (-30%) info
Market Cap: $9.33B info
RGC
May 19, 2026, 4:31 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $27.00
Real-time Price: $18.83 info
Change: -$8.17 (-30%) info
Market Cap: $9.33B info
RGC
May 19, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $27.31
Real-time Price: $18.83 info
Change: -$8.48 (-31%) info
Market Cap: $9.33B info
RGC
May 08, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $29.28
Real-time Price: $18.83 info
Change: -$10.45 (-36%) info
Market Cap: $9.33B info
RGC
Apr 17, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $28.78
Real-time Price: $18.83 info
Change: -$9.95 (-35%) info
Market Cap: $9.33B info
RGC
Mar 30, 2026, 7:18 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $25.50
Real-time Price: $18.83 info
Change: -$6.67 (-26%) info
Market Cap: $9.33B info
RGC
Mar 30, 2026, 6:41 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $25.50
Real-time Price: $18.83 info
Change: -$6.67 (-26%) info
Market Cap: $9.33B info
RGC
Feb 13, 2026, 9:17 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $31.00
Real-time Price: $18.83 info
Change: -$12.17 (-39%) info
Market Cap: $9.33B info